|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/19/14 Urologix Inc 10-K 6/30/14 81:9M American Fin’l P… Inc/FA |
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for the Fiscal Year Ended June 30, 2014 HTML 737K
2: EX-23.1 Consent of Independent Registered Public HTML 24K
Accounting Firm
3: EX-31.1 Certification of CEO Pursuant to Section 302 HTML 32K
4: EX-31.2 Certification of CFO Pursuant to Section 302 HTML 32K
5: EX-32 Certification of Ceo/CFO Pursuant to Section 906 HTML 24K
54: R1 Document And Entity Information HTML 53K
42: R2 Balance Sheets HTML 127K
52: R3 Balance Sheets (Parenthetical) HTML 38K
56: R4 Statements Of Operations HTML 94K
75: R5 Statements Of Shareholders' Equity/(Deficit) HTML 60K
44: R6 Statements Of Cash Flows HTML 120K
51: R7 Nature Of Business HTML 28K
38: R8 Significant Accounting Policies HTML 198K
28: R9 Liquidity HTML 44K
76: R10 Fair Value Measurements HTML 86K
58: R11 Stock Options And Restricted Stock Awards HTML 192K
57: R12 Restructuring HTML 45K
63: R13 Other Accrued Expenses HTML 38K
64: R14 Income Taxes HTML 176K
61: R15 Deferred Income HTML 28K
65: R16 Goodwill HTML 28K
53: R17 Intangible Assets HTML 118K
55: R18 Financing Arrangement HTML 31K
60: R19 Commitments And Contingencies HTML 95K
81: R20 Benefit Plan HTML 27K
71: R21 Gain On Demutualization HTML 28K
48: R22 Significant Accounting Policies (Policy) HTML 118K
59: R23 Significant Accounting Policies (Tables) HTML 160K
50: R24 Fair Value Measurements (Tables) HTML 73K
20: R25 Stock-Based Compensation (Tables) HTML 193K
72: R26 Restructuring (Tables) HTML 40K
78: R27 Other Accrued Expenses (Tables) HTML 37K
33: R28 Income Taxes (Tables) HTML 172K
32: R29 Intangible Assets (Tables) HTML 113K
36: R30 Commitments And Contingencies (Tables) HTML 91K
37: R31 Significant Accounting Policies (Narrative) HTML 72K
(Details)
39: R32 Significant Accounting Policies (Schedule Of HTML 33K
Allowance For Doubtful Accounts) (Details)
18: R33 Significant Accounting Policies (Schedule Of HTML 35K
Inventories) (Details)
69: R34 Significant Accounting Policies (Schedule Of HTML 30K
Property, Plant And Equipment) (Details)
46: R35 Significant Accounting Policies (Schedule Of HTML 31K
Product Warranty Liability) (Details)
49: R36 Significant Accounting Policies (Schedule Of HTML 33K
Shares Used In Earnings Per Share Computation)
(Details)
23: R37 Liquidity (Details) HTML 72K
80: R38 Fair Value Measurements (Narrative) (Details) HTML 41K
12: R39 Fair Value Measurements (Reconciliation Of HTML 34K
Contingent Consideration Liability) (Details)
40: R40 Fair Value Measurements (Reconciliation Of HTML 30K
Goodwill) (Details)
74: R41 Fair Value Measurements (Reconciliation Of HTML 34K
Long-Lived Assets) (Details)
22: R42 Stock Options And Restricted Stock Awards HTML 61K
(Narrative) (Details)
31: R43 Stock Options And Restricted Stock Awards (Amounts HTML 34K
Recognized In Financial Statements Related To
Stock-Based Compensation) (Details)
35: R44 Stock Options And Restricted Stock Awards HTML 32K
(Assumptions Used To Estimate Fair Value Of
Options Granted) (Details)
43: R45 Stock Options And Restricted Stock Awards (Summary HTML 56K
Of Stock Option Activity By Exercise Price)
(Details)
17: R46 Stock Options And Restricted Stock Awards (Summary HTML 58K
Of Stock Option Activity) (Details)
27: R47 Stock Options And Restricted Stock Awards (Summary HTML 43K
Of Non-Vested Options) (Details)
14: R48 Stock Options And Restricted Stock Awards (Summary HTML 47K
Of Non-Vested Restricted Stock Activity) (Details)
73: R49 Restructuring (Narrative) (Details) HTML 38K
21: R50 Restructuring (Schedule Of Restructuring Activity) HTML 29K
(Details)
70: R51 Other Accrued Expenses (Details) HTML 35K
24: R52 Income Taxes (Narrative) (Details) HTML 35K
41: R53 Income Taxes (Schedule Of Components Of Income Tax HTML 54K
Expense (Benefit)) (Details)
13: R54 Income Taxes (Reconciliation Of Statutory Tax HTML 52K
Expense (Benefit) To Actual Tax Expense (Benefit))
(Details)
16: R55 Income Taxes (Schedule Of Components Of Net HTML 61K
Deferred Tax Assets And Liabilities)) (Details)
34: R56 Income Taxes (Schedule Of Expiration Dates And Net HTML 42K
Operating Loss Carryforwards And Credits)
(Details)
19: R57 Deferred Income (Details) HTML 27K
77: R58 Goodwill (Details) HTML 30K
45: R59 Intangible Assets (Narrative) (Details) HTML 35K
62: R60 Intangible Assets (Schedule Of Intangible Assets) HTML 41K
(Details)
26: R61 Intangible Assets (Future Amortization Expense HTML 36K
Related To Net Carrying Amount Of Intangible
Assets) (Details)
29: R62 Financing Arrangement (Details) HTML 28K
68: R63 Commitments And Contingencies (Narrative) HTML 33K
(Details)
66: R64 Commitments And Contingencies (Schedule Of Future HTML 35K
Minimal Annual Lease Commitments) (Details)
47: R65 Commitments And Contingencies (Schedule Of HTML 38K
Estimated Prostiva Payments) (Details)
67: R66 Gain On Demutualization (Details) HTML 26K
79: XML IDEA XML File -- Filing Summary XML 124K
15: EXCEL IDEA Workbook of Financial Reports XLSX 149K
30: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.74M
6: EX-101.INS XBRL Instance -- ulgx-20140630 XML 2.00M
8: EX-101.CAL XBRL Calculations -- ulgx-20140630_cal XML 171K
9: EX-101.DEF XBRL Definitions -- ulgx-20140630_def XML 379K
10: EX-101.LAB XBRL Labels -- ulgx-20140630_lab XML 1.02M
11: EX-101.PRE XBRL Presentations -- ulgx-20140630_pre XML 818K
7: EX-101.SCH XBRL Schema -- ulgx-20140630 XSD 158K
25: ZIP XBRL Zipped Folder -- 0000897101-14-001320-xbrl Zip 147K
EXHIBIT 31.2
CERTIFICATIONS
I, Gregory J. Fluet, certify that:
|
|
|
|
|
|
|
|
1. |
I have reviewed this Form 10-K of Urologix, Inc. |
||
|
|
|
|
|
|
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
||
|
|
|
|
||
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
||
|
|
|
|
||
|
|
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
||
|
|
|
|
||
|
|
|
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
|
|
|
|
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
|
|
|
|
|
(c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
|
|
|
|
|
(d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
|
|
|
|
|
|
|
|
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
||
|
|
|
|
||
|
|
|
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
|
|
|
|
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
|
|
|
|
Date: September 19, 2014 |
|
|
|
|
||
|
|
/s/ Gregory J. Fluet |
|
|
|
Gregory J. Fluet |
|
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/19/14 | None on these Dates | ||
| For Period end: | 6/30/14 | |||
| List all Filings | ||||